Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Endocr Res ; 35(1): 1-16, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20136514

RESUMEN

Pomegranate (Punica granatum) seed linolenic acid isomers were evaluated as selective estrogen receptor modulators (SERMs) in vitro. Punicic acid (PA) inhibited (IC(50)) estrogen receptor (ER) alpha at 7.2 microM, ERbeta at 8.8 microM; alpha-eleostearic acid (AEA) inhibited ERalpha/ERbeta at 6.5/7.8 microM. PA (not AEA) agonized ERalpha/ERbeta (EC(50)) at 1.8/2 microM, antagonizing at 101/80 microM. AEA antagonized ERalpha/ERbeta at 150/140 microM. PA and AEA induced ERalpha and ERbeta mRNA expression in MCF-7, but not in MDA-MB-231. Overall, the results show PA and AEA are SERMs.


Asunto(s)
Ácidos Linoleicos/farmacología , Lythraceae/química , Fitoestrógenos/farmacología , Receptores de Estrógenos/efectos de los fármacos , Receptores de Estrógenos/fisiología , Semillas/química , Neoplasias de la Mama , División Celular/efectos de los fármacos , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Receptor alfa de Estrógeno/genética , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/genética , Receptor beta de Estrógeno/metabolismo , Ácidos Grasos/análisis , Humanos , Isomerismo , Ácidos Linoleicos/química , Ácidos Linoleicos/metabolismo , Ácidos Linoleicos Conjugados/metabolismo , Ácidos Linolénicos/metabolismo , Fitoestrógenos/metabolismo , Aceites de Plantas/química , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Moduladores Selectivos de los Receptores de Estrógeno/metabolismo , Moduladores Selectivos de los Receptores de Estrógeno/farmacología
2.
J Microbiol Biotechnol ; 19(12): 1536-41, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20075615

RESUMEN

The DNA shuffling technique has been used to generate libraries of evolved enzymes in thermostability. We have shuffled two thermostable cytidine deaminases (CDAs) from Bacillus caldolyticus DSM405 (T53) and B. stearothermophilus IFO12550 (T101). The shuffled CDA library (SH1067 and SH1077 from the first round and SH2426 and SH2429 from the second round) showed various patterns in thermostability. The CDAs of SH1067 and SH1077 were more thermostable than that of T53. SH2426 showed 150% increased half-time than that of T53 at 70 degrees C. The CDA of SH2429 showed about 200% decreased thermostability than that of T53 at 70 degrees C. A single amino acid residue replacement that presented between SH1077 and SH2429 contributed to dramatic changes in specific activity and thermostability. On SDS-PAGE, the purified CDA of SH1077 tetramerized, whereas that of SH2429 denatured and became almost monomeric at 80 degrees C. A simulated three-dimensional structure for the mutant CDA was used to interpret the mutational effect.


Asunto(s)
Citidina Desaminasa/química , Citidina Desaminasa/genética , Calor , Bacillus/enzimología , Bacillus/genética , Citidina Desaminasa/metabolismo , Barajamiento de ADN , ADN Bacteriano/genética , ADN Bacteriano/metabolismo , Evolución Molecular Dirigida , Estabilidad de Enzimas , Genes Bacterianos , Microbiología Industrial , Modelos Moleculares , Estructura Cuaternaria de Proteína , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Análisis de Secuencia de Proteína
3.
Toxicol Appl Pharmacol ; 231(3): 401-12, 2008 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-18603276

RESUMEN

A pharmacological dose (2.5-10 microM) of 17alpha-estradiol (17alpha-E(2)) exerted a cytotoxic effect on human leukemias Jurkat T and U937 cells, which was not suppressed by the estrogen receptor (ER) antagonist ICI 182,780. Along with cytotoxicity in Jurkat T cells, several apoptotic events including mitochondrial cytochrome c release, activation of caspase-9, -3, and -8, PARP degradation, and DNA fragmentation were induced. The cytotoxicity of 17alpha-E(2) was not blocked by the anti-Fas neutralizing antibody ZB-4. While undergoing apoptosis, there was a remarkable accumulation of G(2)/M cells with the upregulatoin of cdc2 kinase activity, which was reflected in the Thr56 phosphorylation of Bcl-2. Dephosphorylation at Tyr15 and phosphorylation at Thr161 of cdc2, and significant increase in the cyclin B1 level were underlying factors for the cdc2 kinase activation. Whereas the 17alpha-E(2)-induced apoptosis was completely abrogated by overexpression of Bcl-2 or by pretreatment with the pan-caspase inhibitor z-VAD-fmk, the accumulation of G(2)/M cells significantly increased. The caspase-8 inhibitor z-IETD-fmk failed to influence 17alpha-E(2)-mediated caspase-9 activation, but it markedly reduced caspase-3 activation and PARP degradation with the suppression of apoptosis, indicating the contribution of caspase-8; not as an upstream event of the mitochondrial cytochrome c release, but to caspase-3 activation. In the presence of hydroxyurea, which blocked the cell cycle progression at the G(1)/S boundary, 17alpha-E(2) failed to induce the G(2)/M arrest as well as apoptosis. These results demonstrate that the cytotoxicity of 17alpha-E(2) toward Jurkat T cells is attributable to apoptosis mainly induced in G(2)/M-arrested cells, in an ER-independent manner, via a mitochondria-dependent caspase pathway regulated by Bcl-2.


Asunto(s)
Apoptosis/fisiología , División Celular/fisiología , Estradiol/toxicidad , Fase G2/fisiología , Leucemia-Linfoma de Células T del Adulto/metabolismo , Apoptosis/efectos de los fármacos , Caspasas/genética , Caspasas/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Estradiol/uso terapéutico , Fase G2/efectos de los fármacos , Humanos , Células Jurkat , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Leucemia-Linfoma de Células T del Adulto/genética , Células U937
4.
J Microbiol Biotechnol ; 18(12): 1869-73, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19131686

RESUMEN

An isolate from holothurians was identified as an eicosapentaenoic acid (EPA)-producing bacterium KMG427, which is characterized by EPA synthesis efficiency, by thin layer and gas chromatographic analyses. The EPA production was maximized to more than 10% of the total fatty acids by incubation at 4o degrees C after cell proliferation at 20 degrees C. The isolated bacterium was categorized as Gramnegative, rod-shaped, aerobic, and motile with a single polar flagellum. According to phylogenetic analysis based on morphological and physiological specificities as an EPA-producing bacterium, the isolate KMG427 was found to belong to the genus Shewanella. The 16S rDNA of KMG427 was revealed to have 100% of sequence identity to that of S. hanedai CIP 103207T. Therefore, the isolate might be classified and identified as Shewanella sp. KMG427.


Asunto(s)
Ácido Eicosapentaenoico/metabolismo , Shewanella/clasificación , Cromatografía de Gases , ADN Ribosómico/genética , Ácidos Grasos/biosíntesis , Genes Bacterianos , Lípidos de la Membrana/metabolismo , Fenotipo , Filogenia , ARN Ribosómico 16S/genética , Shewanella/genética , Shewanella/metabolismo , Temperatura
5.
Life Sci ; 71(18): 2145-52, 2002 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-12204772

RESUMEN

Resveratrol is a phytoalexin found in grapes and other foods that has been shown to have anticancer and anti-inflammatory effects. Because protein kinase CKII is involved in cell proliferation and oncogenesis, we examined whether resveratrol could modulate CKII activity. Resveratrol was shown to inhibit the phosphotransferase activity of CKII with IC(50) of about 10 microM. Steady state studies revealed that resveratrol acted as a competitive inhibitor with respect to the substrate ATP. A value of 1.2 microM was obtained for the apparent K(i). Resveratrol also inhibited the catalytic reaction of CKII with GTP as substrate. Furthermore, resveratrol inhibits endogenous CKII activity on protein substrates in HeLa cell lysates. These results suggest that resveratrol is likely to function by inhibiting oncogenic disease, at least in part, through the inhibition of CKII activity.


Asunto(s)
Anticarcinógenos/farmacología , Inhibidores Enzimáticos/farmacología , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Estilbenos/farmacología , Vitis/química , Vino/análisis , Adenosina Trifosfato/metabolismo , Quinasa de la Caseína II , Catálisis , Células HeLa , Humanos , Indicadores y Reactivos , Cinética , Fosforilación , Resveratrol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA